Molecular targets in the National Cancer Institute drug screen
- 1 September 1995
- journal article
- review article
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 121 (9-10), 495-500
- https://doi.org/10.1007/bf01197759
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.JCI Insight, 1995
- Use of the Kohonen Self-organizing Map to Study the Mechanisms of Action of Chemotherapeutic AgentsJNCI Journal of the National Cancer Institute, 1994
- Discrimination techniques applied to the NCI in vitro anti‐tumour drug screen: Predicting biochemical mechanism of actionStatistics in Medicine, 1994
- Cell line-based screening for new anticancer drugsPublished by Springer Science and Business Media LLC ,1994
- Predictive statistics and artificial intelligence in the U.S. National Cancer Institute's drug discovery program for cancer and AIDSThe International Journal of Cell Cloning, 1994
- Neural Computing in Cancer Drug Development: Predicting Mechanism of ActionScience, 1992
- Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell LinesJNCI Journal of the National Cancer Institute, 1991
- Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE AlgorithmJNCI Journal of the National Cancer Institute, 1989
- Intensive treatment of acute leukemia in adults 70 years of age and olderCancer, 1987
- Rubidazone in combination with Ara-C, vincristine and prednisone (ROAP) in the treatment of adult acute leukemia A Southwest Oncology Group StudyAmerican Journal of Clinical Oncology, 1982